News

Sarepta Therapeutics, Inc. and Codiak BioSciences, Inc. announced a global research and option agreement to design and develop engineered exosome therapeutics to deliver gene therapy,…
Read More...

Piramal Enterprises Limited's (PEL) Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), announced that the Company has entered into an…
Read More...

Ascentage Pharma announced a clinical collaboration with Acerta Pharma, the hematology research and development center of excellence of AstraZeneca. Under the terms of the…
Read More...

Merck, known as MSD outside the United States and Canada, announced the completion of the acquisition of Themis, a privately-held company focused on vaccines and immune-modulation…
Read More...

Tonix Pharmaceuticals Holding Corp. announced an expansion of its strategic collaboration with Southern Research to include a study of T cell immune responses to SARS-CoV-2 in…
Read More...

Alpine Immune Sciences, Inc. and AbbVie Inc. announced an exclusive worldwide option and license agreement for ALPN-101, a first-in-class dual CD28/ICOS costimulation antagonist.…
Read More...

Sarepta Therapeutics and Selecta Biosciences, Inc. announced that they have entered into a Research License and Option agreement granting Sarepta an option to license the rights to…
Read More...

Roche announced that the Phase III IMpassion031 study, evaluating Tecentriq (atezolizumab) in combination with chemotherapy (Abraxane, albumin-bound paclitaxel; nab-paclitaxel; followed…
Read More...

Neurocrine Biosciences, Inc. and Takeda Pharmaceutical Company Limited announced a strategic collaboration to develop and commercialize compounds in Takeda’s early-to-mid-stage…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) for the treatment of active non-radiographic axial spondyloarthritis (nr-axSpA),…
Read More...

Orca Bio, a clinical-stage biotechnology company developing high precision allogeneic cell therapies, announced a Series D financing that brings its total capital raised since its 2016…
Read More...

Cell-based cancer vaccines are revolutionizing the treatment of previously incurable cancers. Access to these promising therapies is limited by the high costs of manufacturing at…
Read More...

ISA Pharmaceuticals B.V., a private clinical-stage immunotherapy company, announced plans to initiate a potentially pivotal clinical trial for the combination of ISA101b and Libtayo…
Read More...

Lassen Therapeutics announced it has emerged from stealth and secured $31 million in Series A financing to develop antibodies as potential treatments for fibrosis, rare diseases and…
Read More...

PDS Biotechnology Corporation announced a co-development agreement with Farmacore Biotechnology for Versamune-CoV-2FC, a Versamune-based vaccine aimed at preventing COVID-19 infection.…
Read More...

Jazz Pharmaceuticals plc announced along with its partner PharmaMar that the U.S. Food and Drug Administration (FDA) approved Zepzelca (lurbinectedin) for the treatment of adult…
Read More...

Merck, known as MSD outside the United States and Canada, and Pfizer Inc. announced the presentation of results from the Phase 3 VERTIS CV cardiovascular (CV) outcomes trial that…
Read More...

IDEAYA Biosciences, Inc. and GlaxoSmithKline plc (GSK) announce a strategic partnership in Synthetic Lethality, an emerging field in Oncology. The strategic partnership includes…
Read More...

Sanofi detailed plans on how the Company will make significant investments in France to increase its vaccines research and production capacities, and contribute in responding to future…
Read More...

Monopar Therapeutics Inc. and NorthStar Medical Radioisotopes, LLC (Beloit, WI) announced a 50/50 collaboration to develop potential Radio-Immuno-Therapeutics (RITs) to treat severe…
Read More...